Malinda Itchins Clinical Oncology Society of Australia Annual Scientific Meeting 2026

Abstracts this author is presenting:

• Following the Tumour in Real Time: Liquid Biopsy Across the Disease Trajectory — Lung Cancer Across the Continuum: Precision, Protection and Performance
• Symbiotic-Lung-01: a phase 3 trial of a PD-1/VEGF bispecific antibody, PF-08634404, vs pembrolizumab in combination with platinum-based chemotherapy in first-line for locally advanced or metastatic non-small cell lung cancer — Wednesday Poster Session
• Phase 2 trial of the PD-1/VEGF bispecific antibody, PF-08634404 (SSGJ-707), plus chemotherapy (chemo) in advanced NSCLC: updated results  — Best of the Best Oral Presentations: Clinical research